Key Events This Week
17 Aug: New 52-week and all-time high at Rs.149.75
18 Aug: Stock peaks at Rs.155, upgraded to Buy rating
19 Aug: New 52-week high at Rs.161.1, strong technical signals
20 Aug: Hits Rs.161.6, sixth consecutive day of gains
21 Aug: Week closes at Rs.152.80, slight pullback
Monday, 17 August: New 52-Week and All-Time High at Rs.149.75
Gujarat Kidney & Super Speciality Ltd began the week on a strong note, surging 10.57% to close at Rs.151.10, with an intraday high of Rs.149.75 marking a new 52-week and all-time peak. This represented a 7.83% day gain, significantly outperforming the hospital sector and the broader market, where the Sensex declined 0.15%. The stock demonstrated robust momentum, trading above all key moving averages and signalling sustained bullish sentiment despite a mildly bearish On-Balance Volume (OBV) on a weekly basis.
Tuesday, 18 August: Fresh Highs and Upgrade to Buy Rating
The stock continued its upward trajectory, reaching a new 52-week and all-time high of Rs.155, despite a modest 1.49% day gain to Rs.153.35. The broader market remained subdued with the Sensex falling 0.43%. Notably, MarketsMOJO upgraded Gujarat Kidney & Super Speciality Ltd from Hold to Buy on 18 August, reflecting strong technical momentum and positive quarterly financial results. The upgrade was supported by bullish MACD, Bollinger Bands, and Dow Theory indicators, alongside a surge in delivery volumes, signalling increased investor confidence.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Wednesday, 19 August: New 52-Week High at Rs.161.1 and Strong Technical Momentum
The stock surged to Rs.157.10, a 2.45% day gain, hitting a new 52-week high of Rs.161.1 intraday. This marked the fifth consecutive day of gains, with a cumulative return of 18.09% over this period. The stock outperformed the hospital sector by 3.02% and the Sensex, which declined 0.22%. Technical indicators including weekly MACD, Bollinger Bands, and Dow Theory remained bullish, while RSI suggested some caution. The company’s strong quarterly results, including an 80.69% rise in operating profit and record net sales of Rs.34.29 crores, underpinned the positive sentiment.
Thursday, 20 August: New Peak at Rs.161.6 Amid Market Rally
Gujarat Kidney & Super Speciality Ltd reached a new 52-week and all-time high of Rs.161.6, closing at Rs.157.00 with a slight 0.06% decline on the day. This was the sixth consecutive day of gains, delivering a cumulative return of 20.11%. The broader market rallied with the Sensex up 0.71%, but the stock still outperformed its sector peers by 2.07%. Technical indicators remained predominantly bullish, supported by strong financial metrics and a low Debt to EBITDA ratio of 1.08 times. The Mojo Grade upgrade to Buy and a Mojo Score of 70.0 reflected the stock’s improved fundamentals and market positioning.
Thinking about Gujarat Kidney & Super Speciality Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this micro-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Friday, 21 August: Slight Pullback to Close Week at Rs.152.80
The stock closed the week at Rs.152.80, down 2.68% on the day, following a strong rally earlier in the week. Despite the pullback, the weekly gain stood at a robust 11.82%, significantly outperforming the Sensex’s 0.40% decline. The slight correction may reflect short-term profit-taking after six consecutive days of gains. The stock remains well above all key moving averages, supported by strong delivery volumes and positive technical indicators. The company’s solid financial performance and upgraded Buy rating continue to underpin investor confidence.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-17 | Rs.151.10 | +10.57% | 36,907.46 | -0.15% |
| 2026-08-18 | Rs.153.35 | +1.49% | 36,749.23 | -0.43% |
| 2026-08-19 | Rs.157.10 | +2.45% | 36,577.15 | -0.47% |
| 2026-08-20 | Rs.157.00 | -0.06% | 36,808.42 | +0.63% |
| 2026-08-21 | Rs.152.80 | -2.68% | 36,814.22 | +0.02% |
Key Takeaways
Strong Weekly Outperformance: Gujarat Kidney & Super Speciality Ltd’s 11.82% weekly gain vastly outpaced the Sensex’s 0.40% decline, highlighting the stock’s resilience and appeal amid a mixed market environment.
Multiple New Highs: The stock set successive 52-week and all-time highs from Rs.149.75 on 17 August to Rs.161.6 on 20 August, reflecting sustained buying interest and technical strength.
Technical Momentum: Bullish signals from MACD, Bollinger Bands, Dow Theory, and On-Balance Volume indicators supported the rally, while RSI suggested caution due to potential short-term overbought conditions.
Financial Performance: Record quarterly net sales of Rs.34.29 crores and a 23.1% rise in profit before tax, alongside an 80.69% jump in operating profit, underpin the stock’s strong fundamentals.
Rating Upgrade: MarketsMOJO upgraded the stock from Hold to Buy on 18 August, reflecting improved technical and financial metrics and a Mojo Score of 70.0.
Valuation Considerations: Despite strong gains, the stock trades at premium multiples (P/E ~76x, P/B ~4.8x), indicating high growth expectations and potential volatility risks.
Conclusion
Gujarat Kidney & Super Speciality Ltd’s impressive 11.82% weekly gain amid a declining Sensex underscores its strong market positioning and operational momentum. The stock’s series of new highs, supported by robust quarterly results and a technical upgrade to a Buy rating, reflect growing investor confidence in this micro-cap hospital sector company. While valuation remains elevated, the company’s solid financial health, improving profitability, and positive technical indicators provide a compelling narrative for its recent surge. The slight pullback on the final trading day suggests prudent profit-taking, but the overall trend remains bullish as the stock consolidates above key moving averages. Investors should monitor ongoing quarterly performance and technical signals to gauge the sustainability of this momentum in the coming weeks.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
